ABSTRACT
BACKGROUND: Long-term follow-up studies after endovascular treatment for intracranial aneurysm are still rare and inconclusive. Parenchymal infarctions related to aneurysms have mostly been studied in patients with subarachnoidal hemorrhage (SAH) but infarction rates in patients with endovascularly treated unruptured aneurysms have been little studied. PURPOSE: To determine the frequency of permanent parenchymal lesions as detected in magnetic resonance imaging (MRI) in patients treated with endovascular coiling and to assess aneurysm-related infarctions after the initial treatment period. MATERIAL AND METHODS: A total of 64 patients (32 with primarily ruptured aneurysms) with 69 embolized aneurysms were examined neurologically and by MRI and magnetic resonance angiography (MRA) more than 9 years after the initial endovascular treatment. RESULTS: A total of 14 out of 32 (44%) SAH patients and 11 (34%) patients with unruptured aneurysms had parenchymal lesions in MRI. Infarctions were detected in 10 (31%) SAH patients and the majority (9/10, 90%) of them were aneurysm-related. All aneurysm-related infarctions were detected at the acute hospitalization stage. A total of six (55%) out of 11 infarctions in patients with unruptured aneurysms were aneurysm-related and two of them appeared after the treatment period. Patients with infarction had poorer clinical outcome than patients with no ischemic lesions in MRI. CONCLUSION: Nineteen percent of patients with unruptured and 41% with ruptured aneurysms had aneurysm-related parenchymal lesions in MRI. Most of these were detected during acute treatment period. Aneurysm-related infarctions after treatment period are uncommon.
Subject(s)
Embolization, Therapeutic/methods , Intracranial Aneurysm/pathology , Intracranial Aneurysm/therapy , Magnetic Resonance Imaging/methods , Cerebral Infarction/etiology , Cerebral Infarction/pathology , Female , Follow-Up Studies , Humans , Intracranial Aneurysm/complications , Male , Middle Aged , Observer Variation , Time , Treatment OutcomeABSTRACT
BACKGROUND AND PURPOSE: The aim of this study was to assess the long term outcome after non-aneurysmal subarachnoid haemorrhage (SAH). METHODS: 1154 patients with SAH were treated in our hospital between 1989 and 1999. From this patient population, 97 patients had a non-aneurysmal SAH. All hospital records and death certificates were studied and 33 patients were examined by MRI and MR angiography more than 9 years (mean 12 years) after the initial bleeding. RESULTS: The cohort consisted of 97 patients. Mean follow-up time was 9 years (range 0-19). During the follow-up period, 13 patients (13%) died. Four (4%) died from the initial bleeding less than 5 weeks after the initial haemorrhage. There was no delayed mortality due to SAH or subsequent bleedings. MR angiography revealed no new findings in 33 surviving patients. CONCLUSIONS: Excess mortality during the first year after SAH was higher than 4%, and remained thereafter comparable with the general population. There were no rebleedings and MR imaging did not reveal any vascular pathology that could explain the earlier SAH.
Subject(s)
Subarachnoid Hemorrhage/etiology , Subarachnoid Hemorrhage/therapy , Adult , Aged , Female , Follow-Up Studies , Humans , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging/methods , Male , Middle Aged , Risk Factors , Subarachnoid Hemorrhage/mortality , Treatment OutcomeABSTRACT
INTRODUCTION: In the embolotherapy for the treatment of carotid-cavernous fistulae (CCF) several embolic agents and techniques have been reported. In this series the efficiency of transarterial electrothrombosis with Guglielmi detachable coils (GDC) in direct fistulae and the occlusion with particles, tissue glue and platinum coils in indirect fistulae is studied and the implications of these findings is discussed regarding classification, conservative therapy and follow-up. MATERIAL AND METHODS: Eleven consecutive patients were reviewed retrospectively. Four patients had direct high flow fistulae from the internal carotid arteries and the rest had low flow dural fistulae. Postprocedural clinical outcome and angiographical follow-up are presented. RESULTS: Six patients became symptom free, in 4 patients the symptoms resolved and 1 patient suffered a minor procedural complication. In the 8 follow-up angiographies the fistulae of 7 patients were totally closed, including the 4 patients with direct fistulae. CONCLUSION: Progressive clinical manifestations require embolization to alleviate the symptoms and to prevent further complications of the arteriovenous shunting. Embolization with GDC is a feasible, effective and safe method in direct fistulae.
